Related Experiment Video
Updated: Jul 20, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Cariprazine: A Review in Schizophrenia
1Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand. demail@springer.com.
Cariprazine (Vraylar™) effectively treats schizophrenia symptoms and prevents relapse. This dopamine partial agonist shows particular benefit for patients experiencing negative symptoms, with a favorable tolerability profile.
Area of Science:
- Psychiatry
- Pharmacology
- Neuroscience
Background:
- Schizophrenia is a complex mental disorder with significant unmet treatment needs.
- Current antipsychotic medications offer varying efficacy and tolerability profiles.
- Negative symptoms of schizophrenia are particularly challenging to treat.
Purpose of the Study:
- To review the pharmacological, efficacy, and tolerability data of cariprazine for schizophrenia treatment.
- To evaluate cariprazine's effectiveness in managing positive and negative symptoms.
- To assess cariprazine's long-term relapse prevention capabilities.
Main Methods:
- Narrative review of published pharmacological, efficacy, and tolerability data.
- Analysis of data from Phase IIb and Phase III clinical trials.
- Comparison of cariprazine with placebo and risperidone.
Main Results:
- Cariprazine demonstrated significant efficacy over placebo in improving overall schizophrenia symptoms (PANSS total scores).
- Cariprazine significantly delayed time to relapse compared to placebo in a long-term study.
- Cariprazine showed superior efficacy to risperidone in improving negative symptoms of schizophrenia.
Conclusions:
- Cariprazine is a valuable treatment option for schizophrenia, offering significant efficacy and a generally well-tolerated profile.
- Cariprazine may be particularly beneficial for patients with predominantly negative symptoms.
- Further research may explore cariprazine's role in specific schizophrenia subpopulations.
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Drug Therapy
Antianxiety Medications

